LON:PEBI Port Erin Biopharma Investments (PEBI) Share Price, News & Analysis → “Retirement Secret” Showed 995% Gain Last Time We Shared It (From Stansberry Research) (Ad) Free PEBI Stock Alerts GBX 4.50 +4.50 (+∞) (As of 04/18/2019) Add Compare Share Share Today's Range 4.50▼ 4.5050-Day Range 4.50▼ 4.5052-Week Range 3.15▼ 6Volume8,294 shsAverage Volume43,123 shsMarket Capitalization£1.04 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get Port Erin Biopharma Investments alerts: Email Address Ad Stansberry Research“Retirement Secret” Showed 995% Gain Last Time We Shared ItCentral Banks Buying Gold in Record Numbers Most folks have completely missed the fact that the world's Central Banks have been quietly gobbling up as much gold as they can… Stacking it in their locked vaults on pallets in record numbers.Find out why right here (and see what you can do to get in too with just a few dollars). About Port Erin Biopharma InvestmentsPort Erin Biopharma Investments Limited is a principal investment firm specializing in investments in equity and equity related products. The firm invests in quoted and unquoted companies. It prefers to invest in the biopharma sector and will establish a portfolio of investments in biotechnology and biopharmaceutical companies. The firm may also invest in shares of collective investment schemes with exposure to the biopharma sector and in long-term equity anticipation securities the underlying securities of which will be based on biopharma sector securities and/or indices relating to the biopharma Sector. It may invest in biopharma sector debt, where investments shall not exceed 15 per cent of the net asset value of the company. Port Erin Biopharma Investments Limited was founded on May 3, 2011 and is based in Isle of Man, United Kingdom.Read More PEBI Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart PEBI Stock News HeadlinesNo headlines for this company have been tracked by MarketBeat.com Receive PEBI Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Port Erin Biopharma Investments and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeLON SectorMedical Industry Biotechnology Sub-IndustryN/A Current SymbolLON:PEBI CUSIPN/A CIKN/A Webwww.porterinbiopharma.com Phone+44-1624-620711FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current Ratio59.77 Quick Ratio59.77 Sales & Book Value Annual Sales£28,300.00 Price / Sales36.88 Cash FlowGBX 8.20 per share Price / Cash Flow0.55 Book ValueGBX 8.10 per share Price / Book0.56Miscellaneous Outstanding Shares23,195,600Free FloatN/AMarket Cap£1.04 million OptionableNot Optionable BetaN/A 5G Stocks: The Path Forward is ProfitableClick the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise. Get This Free Report Key ExecutivesMr. Denham Hervey Newall Eke (Age 67)CFO, Fin. Director & Director Key CompetitorsOvoca BioLON:OVBSalvaRx GroupLON:SALVNuformixLON:NFXReNeuron GroupLON:RENEPhysiomicsLON:PYCView All Competitors PEBI Stock Analysis - Frequently Asked Questions How have PEBI shares performed in 2024? Port Erin Biopharma Investments' stock was trading at GBX 4.50 at the beginning of the year. Since then, PEBI shares have increased by 0.0% and is now trading at GBX 4.50. View the best growth stocks for 2024 here. How do I buy shares of Port Erin Biopharma Investments? Shares of PEBI stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.Compare Top Brokerages Here. This page (LON:PEBI) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe A.I. story nobody is telling you (Read ASAP)TradeSmithDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsYour Money is Not SafeAmerican AlternativeFed launches fourth dollar overhaulStansberry ResearchThe only accurate crypto trading system I know …Weiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Port Erin Biopharma Investments Ltd Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.